M
Masashi Mizuguchi
Researcher at University of Tokyo
Publications - 213
Citations - 6288
Masashi Mizuguchi is an academic researcher from University of Tokyo. The author has contributed to research in topics: Encephalopathy & Rotavirus. The author has an hindex of 38, co-authored 203 publications receiving 5347 citations.
Papers
More filters
Journal ArticleDOI
Acute encephalopathy associated with influenza and other viral infections
TL;DR: Various syndromes of acute encephalopathy are reviewed by classifying them into three major categories, caused by metabolic derangement, which includes Reye‐like syndrome, hemorrhagic shock and encephalitis syndrome, and acute necrotizing encephalopathic syndrome.
Journal ArticleDOI
Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions.
TL;DR: Based on the characteristic combination of clinical and pathological findings, acute necrotising encephalopathy of childhood can be distinguished from previously known encephalopathies, including Reye's syndrome.
Journal ArticleDOI
Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes.
Ai Hoshino,Makiko Saitoh,Akira Oka,Akihisa Okumura,Masaya Kubota,Yoshiaki Saito,Jun-ichi Takanashi,Shinichi Hirose,Takanori Yamagata,Hideo Yamanouchi,Masashi Mizuguchi +10 more
TL;DR: A research committee supported by the Japanese government conducted a nationwide survey on the epidemiology of acute encephalopathy in Japan using a questionnaire, finding that Mortality was high in ANE and HSES, but was low in AESD, MERS and HHV-6-associated encephalopathic syndromes.
Journal ArticleDOI
Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan
TL;DR: The clinical, radiological and pathological features of acute necrotizing encephalopathy of childhood, a disease entity established recently, are described and its distinction from clinically similar conditions and from pathologically related conditions, such as the Leigh and Wernicke encephalopathies are discussed.
Journal ArticleDOI
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.
Atsushi Sato,Shinya Kasai,Toshiyuki Kobayashi,Yukio Takamatsu,Okio Hino,Kazutaka Ikeda,Masashi Mizuguchi +6 more
TL;DR: It is shown that mammalian target of rapamycin inhibitors may be useful for the pharmacological treatment of autism spectrum disorder associated with tuberous sclerosis complex and other conditions that result from dysregulated mammalian targets ofRapamycin signalling.